SPPI - スペクトラム・ファ―マス―ティカルズ (Spectrum Pharmaceuticals Inc.) スペクトラム・ファ―マス―ティカルズ

 SPPIのチャート


 SPPIの企業情報

symbol SPPI
会社名 Spectrum Pharmaceuticals Inc (スペクトラム・ファ―マス―ティカルズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 スペクトラム・ファーマシューティカルズ(Spectrum Pharmaceuticals Inc.)はバイオ技術会社である。同社は腫瘍学及び血液学の医薬品製品セグメントの開発・商品化を通じて営業している。同社には、癌の各タイプに対応する商業ステージと開発ステージからなる製品ポートフォリオがある。同社は非ホジキンリンパ腫(NHL)、進行性転移性結腸直腸癌(mCRC)、急性リンパ芽球性白血病(ALL)および多発性骨髄腫(MM)を含む各タイプの癌を対象とする6つの承認された腫瘍/血液製剤製品がある。また、化学療法誘発性好中球減少症のROLONTIS、非筋肉浸潤性膀胱癌(NMIBC)患者の膀胱腫瘍の経尿道的切除後の即時膀胱内注入のためのQAPZOLA、及び乳癌と肺癌を含む広範囲の固形腫瘍を有する患者の治療に使用される汎ヒト上皮増殖因子受容体(HER)阻害剤であるPOZIOTINIBを含む中期~後期段階で3つの薬剤を開発する。   スペクトラム・ファ―マス―ティカルズは米国の製薬会社。腫瘍と血液がん分野に抗がん剤に焦点を置き、大腸がん、濾胞非ホジキンリンパ腫、末梢T細胞リンパ腫、リンパ性白血病の抗がん剤を製造、販売。また、多発性骨髄腫と非筋層浸潤性膀胱がんの治療薬を開発中。製品は米国、欧州、日本で販売される。   Spectrum Pharmaceuticals is a biopharmaceutical company focused on acquiring, developing, and commercializing novel and targeted oncology therapies. Spectrum has a strong track record of successfully executing across the biopharmaceutical business model, from in-licensing and acquiring differentiated drugs, clinically developing novel assets, successfully gaining regulatory approvals and commercializing in a competitive healthcare marketplace. Spectrum has a late-stage pipeline with novel assets that serve areas of unmet need. This pipeline has the potential to transform the company in the near future.
本社所在地 11500 South Eastern Avenue Suite 240 Henderson NV 89052 USA
代表者氏名 Stuart Mitchell Krassner スチュアート・ミッチェル・クラースナー
代表者役職名 Chairman of the Board 取締役会会長
電話番号 +1 702-835-6300
設立年月日 32112
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 215人
url www.sppirx.com
nasdaq_url https://www.nasdaq.com/symbol/sppi
adr_tso
EBITDA EBITDA(百万ドル) -88.65300
終値(lastsale) 15.74
時価総額(marketcap) 1667792110.12
時価総額 時価総額(百万ドル) 1541.701
売上高 売上高(百万ドル) 119.62800
企業価値(EV) 企業価値(EV)(百万ドル) 1311.47
当期純利益 当期純利益(百万ドル) -10.98500
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Spectrum Pharmaceuticals Inc. revenues decreased 14% to $54.7M. Net loss decreased 95% to $2.1M. Revenues reflect Product sales net decrease of 9% to $51.9M License fees and service revenue decrease of 56% to $2.8M. Lower net loss reflects Other expense increase from $650K to $58.5M (income) Interest Exp-Net of Capitalized Interest decrease of 62% to $1.8M (expense).

 SPPIのテクニカル分析


 SPPIのニュース

   Implied Volatility Surging for Spectrum Pharmaceuticals (SPPI) Stock Options  2021/06/25 04:22:13 Yahoo Finance
Implied Volatility Surging for Spectrum Pharmaceuticals (SPPI) Stock Options Yahoo Finance
   Spectrum Pharmaceuticals rises defying a series of insider selling  2021/06/23 13:52:35 Seeking Alpha
   IPO Preview: Full Truck Alliance, Sprinklr, Mister Car Wash, Soulgate Lead Busy Week Of 10+ Offerings  2021/06/21 22:06:39 Benzinga
The week of June 21 is setting up to be one of the busiest IPO weeks in some time with more than dozen companies that could go public with listings. Here is a look at some of the biggest IPOs of the week with the details investors should know. Unicycle Therapeutics: Biotech company Unicycle Therapeutics Inc (NASDAQ: UNCY ) is focused on preventing chronic kidney diseases. The company has two drugs licensed from Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI ). The company plans to sell 2.6 million shares at a price point of $8.50 to $10.50. Full Truck Alliance: The worlds largest digital freight platform Full Truck Alliance plans to sell 82.5 million ADS at a price point of $17 to $19. The company makes logistics better for powering Chinas transportation and infrastructure. The company operates in more than 300 cities in China, the worlds largest road transportation market at $951.5 billion in 2020. Full Truck Alliance represented 20% of all heavy-duty and medium-duty trucking fulfilled orders in 2020 for China.
   Traders should follow this: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), MFA Financial, Inc. (NYSE:MFA)  2021/06/08 21:34:44 Stock Equity
Spectrum Pharmaceuticals, Inc. (SPPI) with the stream of -0.73% also noticed, India MFA Financial, Inc. (MFA) encountered a rapid change of 2.18% in the last hour of Tuesdays trading session. The post Traders should follow this: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), MFA Financial, Inc. (NYSE:MFA) appeared first on Stocks Equity .
   B.Riley Financial Sticks to Their Buy Rating for Spectrum Pharmaceuticals (SPPI)  2021/06/07 14:15:08 Smarter Analyst
In a report released today, Mayank Mamtani from B.Riley Financial maintained a Buy rating on Spectrum Pharmaceuticals (SPPI), with a price target of The post B.Riley Financial Sticks to Their Buy Rating for Spectrum Pharmaceuticals (SPPI) appeared first on Smarter Analyst .
   Spectrum Pharmaceuticals, Inc. Shares Close the Day 13.7% Higher - Daily Wrap  2021/05/11 22:30:00 Kwhen Finance
Spectrum Pharmaceuticals, Inc. (SPPI) shares closed today 13.7% higher than it did at the end of yesterday. The stock is currently down 10.3% year-to-date, down 1.6% over the past 12 months, and down 57.0% over the past five years. Today, the Dow Jones Industrial Average rose 1.1%, and the S&P 500 rose 1.5%. Trading Activity Shares traded as high as $3.49 and as low as $2.91 this week.Shares closed 3e+1% below its 52-week high and 3e+1% above its 52-week low.Trading volume this week was 28.3% higher than the 10-day average and 14.3% higher than the 30-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 1.4. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold.The stock closed at 9.7% higher than its 5-day moving average, 13.2% higher than its 20-day moving average, and 2.0% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -198.5% The company's stock price performance over the past 12 months lags the peer average by -101.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Spectrum Pharmaceuticals Provides Update on ROLONTIS® (eflapegrastim) Pre-Approval Inspection  2021/03/16 11:00:00 Business Wire
HENDERSON, Nev.--(BUSINESS WIRE)---- $SPPI--Spectrum Pharmaceuticals Provides Update on ROLONTIS® (eflapegrastim) Pre-Approval Inspection
   Thinking about buying stock in Vir Biotechnology, Spectrum Pharmaceuticals, Aveo Pharmaceuticals, Geovax Labs, or Comstock Mining?  2021/03/11 13:34:00 PR Newswire
NEW YORK, March 11, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VIR, SPPI, AVEO, GOVX, and LODE. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Spectrum Pharmaceuticals Presents Twice Daily Dosing Data for Poziotinib at the ESMO TAT Virtual Congress 2021  2021/03/02 16:45:00 Business Wire
HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Presents Twice Daily Dosing Data for Poziotinib at the ESMO TAT Virtual Congress 2021
   Spectrum Pharmaceuticals Does Earnings Surprise History Hold Any Clue for Stock market Insights & financial analysis  2021/02/25 05:54:00 Stock Market Daily
Spectrum Pharmaceuticals announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   Spectrum Pharmaceuticals Announces Two Presentations at Upcoming ESMO TAT Virtual Congress 2021  2021/02/23 12:00:00 Business Wire
HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Announces Two Presentations at Upcoming ESMO TAT Virtual Congress 2021

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 スペクトラム・ファ―マス―ティカルズ SPPI Spectrum Pharmaceuticals Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)